Laboratory of Pharmacology and Experimental Therapeutics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
J Neuroinflammation. 2012 Jul 6;9:103. doi: 10.1186/1742-2094-9-103.
It is well known that methamphetamine (METH) is neurotoxic and recent studies have suggested the involvement of neuroinflammatory processes in brain dysfunction induced by misuse of this drug. Indeed, glial cells seem to be activated in response to METH, but its effects on microglial cells are not fully understood. Moreover, it has been shown that cytokines, which are normally released by activated microglia, may have a dual role in response to brain injury. This led us to study the toxic effect of METH on microglial cells by looking to cell death and alterations of tumor necrosis factor-alpha (TNF-α) and interleukine-6 (IL-6) systems, as well as the role played by these cytokines.
We used the N9 microglial cell line, and cell death and proliferation were evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling assay and incorporation of bromodeoxyuridine, respectively. The TNF-α and IL-6 content was quantified by enzyme-linked immunosorbent assay, and changes in TNF receptor 1, IL-6 receptor-alpha, Bax and Bcl-2 protein levels by western blotting. Immunocytochemistry analysis was also performed to evaluate alterations in microglial morphology and in the protein expression of phospho-signal transducer and activator of transcription 3 (pSTAT3).
METH induced microglial cell death in a concentration-dependent manner (EC50 = 1 mM), and also led to significant morphological changes and decreased cell proliferation. Additionally, this drug increased TNF-α extracellular and intracellular levels, as well as its receptor protein levels at 1 h, whereas IL-6 and its receptor levels were increased at 24 h post-exposure. However, the endogenous proinflammatory cytokines did not contribute to METH-induced microglial cell death. On the other hand, exogenous low concentrations of TNF-α or IL-6 had a protective effect. Interestingly, we also verified that the anti-apoptotic role of TNF-α was mediated by activation of IL-6 signaling, specifically the janus kinase (JAK)-STAT3 pathway, which in turn induced down-regulation of the Bax/Bcl-2 ratio.
These findings show that TNF-α and IL-6 have a protective role against METH-induced microglial cell death via the IL-6 receptor, specifically through activation of the JAK-STAT3 pathway, with consequent changes in pro- and anti-apoptotic proteins.
众所周知,甲基苯丙胺(METH)具有神经毒性,最近的研究表明,神经炎症过程参与了滥用这种药物引起的大脑功能障碍。事实上,胶质细胞似乎对 METH 有反应而被激活,但它对小胶质细胞的影响尚未完全阐明。此外,已经表明,细胞因子通常由激活的小胶质细胞释放,可能在应对脑损伤时具有双重作用。这促使我们通过观察细胞死亡以及肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)系统的改变来研究 METH 对小胶质细胞的毒性作用,以及这些细胞因子所起的作用。
我们使用了 N9 小胶质细胞系,通过末端脱氧核苷酸转移酶 dUTP 缺口末端标记法和溴脱氧尿苷掺入分别评估细胞死亡和增殖。通过酶联免疫吸附试验定量测定 TNF-α 和 IL-6 的含量,并通过 Western blot 测定 TNF 受体 1、IL-6 受体-α、Bax 和 Bcl-2 蛋白水平的变化。还进行了免疫细胞化学分析,以评估小胶质细胞形态和磷酸信号转导和转录激活因子 3(pSTAT3)的蛋白表达的改变。
METH 以浓度依赖性方式诱导小胶质细胞死亡(EC50=1mM),并导致明显的形态变化和细胞增殖减少。此外,该药物在 1 小时时增加了 TNF-α 细胞外和细胞内水平以及其受体蛋白水平,而在暴露后 24 小时时增加了 IL-6 及其受体水平。然而,内源性促炎细胞因子对 METH 诱导的小胶质细胞死亡没有贡献。另一方面,外源性低浓度的 TNF-α 或 IL-6 具有保护作用。有趣的是,我们还验证了 TNF-α 的抗凋亡作用是通过激活 IL-6 信号转导介导的,特别是通过 Janus 激酶(JAK)-STAT3 途径,这反过来又导致 Bax/Bcl-2 比值的下调。
这些发现表明,TNF-α 和 IL-6 通过 IL-6 受体对 METH 诱导的小胶质细胞死亡具有保护作用,特别是通过激活 JAK-STAT3 途径,从而导致促凋亡和抗凋亡蛋白的变化。